Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures?
Fusco
Vittorio
V
Baraldi
Anna
A
Loidoris
Anastasios
A
Ciuffreda
Libero
L
Galassi
Claudia
C
Goia
Franco
F
Scoletta
Matteo
M
Berrone
Sid
S
Benech
Arnaldo
A
Ortega
Cinzia
C
Berruti
Alfredo
A
D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003777:Dental Prophylaxis; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007275:Injections, Intravenous; D007571:Jaw Diseases / Q000139:chemically induced* / Q000517:prevention & control; D010020:Osteonecrosis / Q000139:chemically induced* / Q000517:prevention & control; D016016:Proportional Hazards Models; D013997:Time Factors
D050071:Bone Density Conservation Agents; D004164:Diphosphonates